Skip to main content

Table 2 Clinicopathological differences between cases with cutaneous LMS and subcutaneous LMS

From: Optimal surgical treatment for paratesticular leiomyosarcoma: retrospective analysis of 217 reported cases

  Cutaneous LMS (n = 42) Subcutaneous LMS (n = 166) p-value
Age 63 [31-89] 62 [1- 88] 0.976
Size (cm) 4.00 [0.50-12.40] 5.00 [0.50-50.00] 0.002
Definitive surgery    
 Simple tumorectomy 32 (82.1%) 19 (11.9%) <0.001
 With orchiectomy 7 (17.9%) 140 (88.1%)  
Surgical margin    
 Negative 20 (100.0%) 36 (81.8%) 0.049
 Positive 0 (0.0%) 8 (18.2%)  
Tumor grade    
 Grade 1 13 (41.9%) 40 (27.2%) 0.101
 Grade 2 11 (35.5%) 50 (34.0%)  
 Grade 3 7 (22.6%) 57 (38.8%)  
Adjuvant radiation therapy    
 No 34 (89.5%) 121 (81.8%) 0.333
 Yes 4 (10.5%) 27 (18.2%)  
Adjuvant chemotherapy    
 No 36 (94.7%) 137 (92.6%) 1.000
 Yes 2 (5.3%) 11 (7.4%)